PTC Therapeutics Inc (PTCT)
25.37
+0.67
(+2.71%)
USD |
NASDAQ |
Apr 19, 16:00
25.24
-0.13
(-0.51%)
After-Hours: 20:00
PTC Therapeutics Cash from Financing (TTM): 646.40M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 646.40M |
September 30, 2023 | 328.83M |
June 30, 2023 | 185.48M |
March 31, 2023 | 170.88M |
December 31, 2022 | 167.95M |
September 30, 2022 | -130.61M |
June 30, 2022 | 12.36M |
March 31, 2022 | 12.51M |
December 31, 2021 | 20.88M |
September 30, 2021 | 56.61M |
June 30, 2021 | 696.69M |
March 31, 2021 | 659.76M |
December 31, 2020 | 668.72M |
September 30, 2020 | 630.91M |
June 30, 2020 | 370.21M |
March 31, 2020 | 405.98M |
December 31, 2019 | 613.21M |
September 30, 2019 | 614.65M |
June 30, 2019 | 237.38M |
March 31, 2019 | 356.16M |
December 31, 2018 | 131.57M |
September 30, 2018 | 129.70M |
June 30, 2018 | 126.32M |
Date | Value |
---|---|
March 31, 2018 | 44.69M |
December 31, 2017 | 44.22M |
September 30, 2017 | 42.41M |
June 30, 2017 | 41.59M |
March 31, 2017 | 1.597M |
December 31, 2016 | 0.968M |
September 30, 2016 | 0.948M |
June 30, 2016 | 146.02M |
March 31, 2016 | 151.08M |
December 31, 2015 | 154.06M |
September 30, 2015 | 272.44M |
June 30, 2015 | 126.83M |
March 31, 2015 | 122.00M |
December 31, 2014 | 237.13M |
September 30, 2014 | 118.69M |
June 30, 2014 | 115.47M |
March 31, 2014 | 250.20M |
December 31, 2013 | 187.44M |
September 30, 2013 | 186.77M |
June 30, 2013 | 188.05M |
March 31, 2013 | 80.13M |
December 31, 2012 | 22.41M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-130.61M
Minimum
Sep 2022
696.69M
Maximum
Jun 2021
335.20M
Average
328.83M
Median
Sep 2023
Cash from Financing (TTM) Benchmarks
Sarepta Therapeutics Inc | 125.00M |
Catalyst Pharmaceuticals Inc | -10.86M |
Pfizer Inc | 26.07B |
Geron Corp | 362.02M |
Perspective Therapeutics Inc | 0.785M |